Realta Investment Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $633K | Buy |
2,516
+192
| +8% | +$41.3K | 0.2% | 112 |
|
|
2026
Q1 | $506K | Sell |
2,324
-230
| -9% | -$51K | 0.18% | 127 |
|
|
2025
Q4 | $583K | Buy |
2,554
+189
| +8% | +$43.1K | 0.19% | 112 |
|
|
2025
Q3 | $548K | Sell |
2,365
-2,720
| -53% | -$554K | 0.18% | 110 |
|
|
2025
Q2 | $944K | Sell |
5,085
-549
| -10% | -$102K | 0.37% | 64 |
|
|
2025
Q1 | $1.18M | Buy |
5,634
+180
| +3% | +$35K | 0.54% | 48 |
|
|
2024
Q4 | $988K | Sell |
5,454
-1,239
| -19% | -$228K | 0.41% | 57 |
|
|
2024
Q3 | $1.31M | Sell |
6,693
-2,814
| -30% | -$525K | 0.6% | 42 |
|
|
2024
Q2 | $1.63M | Buy |
9,507
+347
| +4% | +$57.5K | 0.32% | 70 |
|
|
2024
Q1 | $1.67M | Sell |
9,160
-456
| -5% | -$78.6K | 0.34% | 63 |
|
|
2023
Q4 | $1.49M | Sell |
9,616
-611
| -6% | -$89.1K | 0.34% | 64 |
|
|
2023
Q3 | $1.38M | Sell |
10,227
-2,852
| -22% | -$419K | 0.32% | 69 |
|
|
2023
Q2 | $1.76M | Sell |
13,079
-431
| -3% | -$63.2K | 0.39% | 51 |
|
|
2023
Q1 | $2.15M | Buy |
13,510
+91
| +0.7% | +$13.9K | 0.52% | 35 |
|
|
2022
Q4 | $2.17M | Buy |
13,419
+616
| +5% | +$94.5K | 0.53% | 36 |
|
|
2022
Q3 | $1.72M | Buy |
12,803
+535
| +4% | +$76.8K | 0.45% | 45 |
|
|
2022
Q2 | $1.89M | Sell |
12,268
-518
| -4% | -$79.2K | 0.46% | 45 |
|
|
2022
Q1 | $2.07M | Buy |
12,786
+1,763
| +16% | +$256K | 0.41% | 47 |
|
|
2021
Q4 | $1.49M | Buy |
11,023
+285
| +3% | +$33.7K | 0.33% | 66 |
|
|
2021
Q3 | $1.16M | Buy |
10,738
+490
| +5% | +$56K | 0.27% | 84 |
|
|
2021
Q2 | $1.15M | Sell |
10,248
-345
| -3% | -$38.9K | 0.27% | 90 |
|
|
2021
Q1 | $1.15M | Buy |
10,593
+689
| +7% | +$73.7K | 0.3% | 84 |
|
|
2020
Q4 | $1.06M | Buy |
9,904
+173
| +2% | +$16.6K | 0.3% | 71 |
|
|
2020
Q3 | $852K | Sell |
9,731
-2,380
| -20% | -$224K | 0.29% | 82 |
|
|
2020
Q2 | $1.19M | Buy |
12,111
+1,373
| +13% | +$121K | 0.39% | 54 |
|
|
2020
Q1 | $818K | Buy |
10,738
+99
| +0.9% | +$8.43K | 0.35% | 66 |
|
|
2019
Q4 | $933K | Buy |
10,639
+917
| +9% | +$76.1K | 0.26% | 86 |
|
|
2019
Q3 | $738K | Buy |
9,722
+1,746
| +22% | +$120K | 0.2% | 113 |
|
|
2019
Q2 | $581K | Sell |
7,976
-822
| -9% | -$64.6K | 0.16% | 152 |
|
|
2019
Q1 | $703K | Buy |
+8,798
| New | +$720K | 0.32% | 88 |
|
Other funds holding ABBV
Realta Investment Advisors's ABBV Position: Q2 2026 in Review
Realta Investment Advisors increased its AbbVie (ABBV) stake by 8.3% in Q2 2026, buying an estimated $41.3K and bringing the position to 2,516 shares worth $633K. The position accounts for 0.2% of the portfolio, ranked #112.
Realta Investment Advisors first reported a position in ABBV in Q1 2019 and has held it in 30 quarters since. The position peaked at $2.17M in Q4 2022. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Realta Investment Advisors held 2,516 shares of AbbVie worth $633K as of Q2 2026.
- Realta Investment Advisors bought 192 AbbVie shares in Q2 2026, an estimated $41.3K.
- AbbVie made up 0.2% of Realta Investment Advisors's portfolio in Q2 2026, its #112 holding.
- Realta Investment Advisors first reported a position in AbbVie in Q1 2019 and has held it in 30 quarters since.
- Realta Investment Advisors's AbbVie position peaked at $2.17M in Q4 2022.
- 4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Realta Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.